Shenzhen Mindray Biomedical Electronic equipment on display at an exhibition in Shanghai. The company’s stock hit a record high of 200 yuan at one point last week. Photo: SCMP
Wuhan coronavirus to bump up health care stocks, but worst not over for airlines and Macau casinos, analysts say
- Investors respond to outbreak by backing pharmaceutical and medical diagnostic companies’ shares
- No long-term financial benefit for big diversified Chinese drug makers from epidemic, Morningstar says
Shenzhen Mindray Biomedical Electronic equipment on display at an exhibition in Shanghai. The company’s stock hit a record high of 200 yuan at one point last week. Photo: SCMP